Cytori currently sells the Celution® 800/CRS System in Europe and Asia Pacific for use in the areas of cosmetic and reconstructive surgery. Reconstructive surgery aims to repair damage resulting from traumatic disease or injuries which can affect quality of life and have a psychological impact on the patient. Using the patient’s own adipose tissue, physicians can formulate a cell-enriched fat graft which may be re-introduced into the patient to treat a variety of soft tissue defects and conditions.
We believe that the cell-enriched reconstruction procedure could fill currently unmet medical needs in the field of reconstructive surgery. Up to 35%1 of the greater than 1 million HIV positive individuals in the US suffer from HIV facial lipodystrophy, a condition for which there is no generally accepted treatment. 75% of the greater than 610,000 women in Europe and the US diagnosed with breast cancer annually2,3 are eligible for a partial mastectomy and lack viable reconstructive options4.
The Celution® 800/CRS System was introduced in the first quarter of 2008 into the European and Asian cosmetic and reconstructive surgery markets. To further broaden physician adoption, Cytori initiated the RESTORE-2 post marketing study in 2008 to provide additional clinical data and support reimbursement for the procedure. >>Learn more about RESTORE-2
There is ongoing demand for the product among surgeons in Europe and Asia Pacific performing private pay procedures including breast reconstruction following partial mastectomy, breast augmentation, implant salvage, buttock enhancement, facial rejuvenation, and HIV facial lipodystrophy.
--------------------------------------------------------------------------------
1. Hornberger, J. et. al. “Cost Consequences of HIV Associated Lipoatrphy.” AIDS Care. Vol. 21, Issue (5). May 2009. 664-671. Retrieved July 23, 2009.
2. Boyle P & Ferlay J. (2005). Cancer incidence and mortality in Europe, 2004. Annals of Oncology (16), 481-488.
3. American Cancer Society. (2007). Breast Cancer Facts & Figures 2007-2008. Atlanta: American Cancer Society, Inc. Retrieved December 10, 2007.
4. Fitzal F, Gnant M. (2006). Breast conservation: evolution of surgical strategies. Breast J (12), 5 Suppl 2, S165-73.